NextGen Biomed 2026, London, UK, March 24-25
Conference
Event
-
February 25, 2026
Don't miss genOway's presentation:
🕛 Wednesday, March 25, 2026 | 3 p.m. GMT
📍 Conference Room 6 - Gielgud
🎓 Presenter: Kader Thiam, CSO & SVP – Discovery, Preclinical Models & Services
📢 Presentation Title: Enhancing the Translational Relevance of Immunotherapies in Preclinical Models
- Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments, without side effects
- Evidencing the recruitment of human immune cells to tumor microenvironment, as well as their activation status
- Highlighting the key role of the myeloid compartment in the translatable assessment of biologic's safety in humanized models
Come visit us at Booth #48!
Our team of scientific experts onsite would be happy to welcome you at our booth.
NextGen Biomed 2026, London, UK, March 24-25
Get in touch
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Featured in 600+ scientific articles
Collaborative approach
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Robust validation data on catalog models
Generated with biopharma partners and in-house
Innovative technologies
and guaranteed freedom to operate
Easy access to models
Models with certified health status from professional breeders in US and Europe